Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C

被引:0
|
作者
Liang-Jen Wang
Shuo-Wei Chen
Chih-Ken Chen
Cho-Li Yen
Jia-Jang Chang
Tsung-Shih Lee
Ching-Jung Liu
Li-Wei Chen
Rong-Nan Chien
机构
[1] Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine,Department of Child and Adolescent Psychiatry
[2] Liver Research Unit,Department of Psychiatry
[3] Chang Gung Memorial Hospital,undefined
[4] Chang Gung University College of Medicine,undefined
[5] Chang Gung Memorial Hospital,undefined
[6] Chang Gung University College of Medicine,undefined
来源
关键词
Anxiety; Depression; Interferon; Ribavirin; Hepatitis C;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Early Effect of Peginterferon Alpha-2b plus Ribavirin Treatment on Blood Pressure and Insulin Resistance in Patients with Chronic Hepatitis C
    Taskoparan, Muharrem
    Serin, Ender
    Gokturk, Huseyin Savas
    Icer, Mustafa Okan
    Abaci, Kutlu
    Ozer, Birol
    Zumrutdal, Aysegul
    Yilmaz, Ugur
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 875 - 879
  • [32] COST-EFFECTIVENESS ANALYSIS OF PEG-INTERFERON ALPHA-2A PLUS RIBAVIRIN VERSUS CONVENTIONAL INTERFERON ALPHA-2A PLUS RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Chen, W.
    Wei, L.
    VALUE IN HEALTH, 2011, 14 (07) : A280 - A280
  • [33] Area-under-the-curve for peginterferon alpha-2a and peginterferon alpha-2b is not related to body weight in treatment-naive patients with chronic hepatitis C
    Bruno, R
    Sacchi, P
    Maiocchi, L
    Zocchetti, C
    Ciappina, V
    Patruno, S
    Filice, G
    ANTIVIRAL THERAPY, 2005, 10 (02) : 201 - 205
  • [34] Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis
    Druyts, Eric
    Mills, Edward J.
    Nachega, Jean
    O'Regan, Christopher
    Cooper, Curtis L.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 11 - 21
  • [35] Safety and efficacy of peginterferon alpha-2b plus ribavirin in pre-cirrhotic and cirrhotic patients with chronic hepatitis C
    Marrache, F
    Ripault, MP
    Consigny, Y
    Hatem, DC
    Boyer, N
    Martinot, M
    Degott, C
    Valla, D
    Marcellin, P
    GASTROENTEROLOGY, 2003, 124 (04) : A769 - A769
  • [36] Highly effective peginterferon alpha-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
    Yang, Suh Yoon
    Lee, Hyun Woong
    Lee, Youn Jae
    Park, Sung Jae
    Yoo, Ki Young
    Kim, Hyung Joon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (02) : 125 - 130
  • [37] HIGHLY EFFECTIVE PEGINTERFERON ALPHA-2A PLUS RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS C IN PATIENTS WITH HEMOPHILIA
    Lee, Hyun Woong
    Kim, Hyung J.
    Lee, Youn-Jae
    Park, Sung Jae
    Baek, Eun Kyung
    Kim, Ki-Seong
    Cha, Bong Ki
    Lee, Seung-Yong
    Oh, Hyoung-Chul
    Choi, Chang Hwan
    Kim, Jung Uk
    Do, Jae Hyuk
    Kim, Jae G.
    Chang, Sae Kyung
    HEPATOLOGY, 2009, 50 (04) : 1020A - 1020A
  • [38] Efficacy and factors influencing treatment with peginterferon alpha-2a and ribavirin in elderly patients with chronic hepatitis C
    Yu, Jian-Wu
    Sun, Li-Jie
    Kang, Peng
    Yan, Bing-Zhu
    Zhao, Yong-Hua
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (02) : 185 - 192
  • [39] Pegylated interferon alpha-2a (Pegasys) versus pegylated interferon alpha-2b (Pegintron) in the treatment of chronic hepatitis C infection
    Anees, MR
    Reddymasu, S
    Bejjanki, HR
    Caldito, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S142 - S142